Technical References List

Technical References by Product - Each List In Reverse Chronological Order

Human Skin Tissue Equivalents:

EpiDerm™ Technical References

EpiDerm-201™ (Underdeveloped Tissue) Technical References

EpiDermFT™ Technical References

MelanoDerm™ Technical References

Melanoma Technical References

================

Other Human Tissue Equivalents:

EpiAirway™ Technical References

EpiOcular™ Technical References

EpiOral™/EpiGingival™ Technical References

EpiVaginal™ Technical References

================

Human Dendritic Cells:

Dendritic Cells Technical References

================

Technical References in Numerical Order - Oldest to Most Recent

( This Page ) (579 to 598) (599 to 611)

559.	NEW!	IN VITRO SKIN IRRITATION TESTING: IMPROVING THE SENSITIVITY OF THE EPIDERM SKIN IRRITATION TEST PROTOCOL. Kandárová, H., Hayden, P., Klausner, M., Kubilus, J., Kearney, P., and Sheasgreen, J. MatTek Corporation, Ashland, MA, USA. ATLA, 37, 671–689, 2009.
560.	NEW!	EVALUATION OF EPIDERM FULL THICKNESS-300 (EFT-300) AS AN IN VITRO MODEL FOR SKIN IRRITATION: STUDIES ON ALIPHATIC HYDROCARBONS. Mallampati1, R., Patlolla1, R.R., Agarwal1, S., Babu2, R.J., Hayden3, P., Klausner3, M., Singh1, M.S. 1College of Pharmacy and Pharmaceutical Sciences, Florida A&M University, Tallahassee, FL 32307, USA. 2Harrison School of Pharmacy, Auburn University, Auburn, AL 36849, USA. 3MatTek Corporation, 200 Homer Avenue, Ashland, MA 01721, USA. Toxicology in Vitro, 24, 669-676, (2010).
561.	NEW!	NON-ANIMAL APPROACHES FOR CONSUMER SAFETY RISK ASSESSMENTS: UNILEVER’S SCIENTIFIC RESEARCH PROGRAMME. Carmichael, P., Davies, M., Dent, M., Fentem, J., Fletcher, S., Gilmour, N., MacKay, C., Maxwell, G., Merolla, L., Pease, C., Reynolds, F., and Westmoreland, C. Safety & Environmental Assurance Centre (SEAC), Unilever, Colworth Science Park, Sharnbrook, Bedford, UK. ATLA, 37, 595–610, (2009).
562.	NEW!	ESTABLISHMENT OF A 3D AIRWAY MODEL FOR RESPIRATORY INFECTION. Published by Battelle Memorial Institute. (2010).
563.	NEW!	RELATIVE BIOLOGICAL EFFECTIVENESS OF PULSED AND CONTINUOUS 20 MEV PROTONS FOR MICRONUCLEUS INDUCTION IN 3D HUMAN RECONSTRUCTED SKIN TISSUE. Schmid1, T.E., Dollinger2, G., Hable2, V., Greubel2, C., Zlobinskaya1, O., Michalski1, D., Molls1, M., and Röper1, B, 1Department of Radiation Oncology, Technische Universitaet Muenchen, Germany; 2Institute for Applied Physics and Metrology, Universitaet der Bundeswehr Muenchen, Neubiberg, Germany. Radiother Oncol. 2010 Apr,95 (1): 66–72 Epub 2010 Mar 26.
564.	NEW!	DEVELOPMENT OF A VAPOR CUP DOSING METHOD FOR EVALUATION OF CHEMICAL TOXICITY IN THE EPIAIRWAY™ ORGANOTYPIC IN VITRO HUMAN AIRWAY MODEL. Jackson, Jr., G.R., Bolmarcich, J., Oldach, J., Klausner, M. and Patrick J. Hayden. MatTek Corporation, Ashland, Massachusetts, USA. Presented at 49th Annual SOT Meeting, Salt Lake City, Utah (2010).
565.	NEW!	FURTHER DEVELOPMENT OF AN EPIDERM™ IN VITRO SKIN IRRITATION TEST FOR THE GLOBALLY HARMONIZED SYSTEM (GHS-SIT) OF CLASSIFICATION AND LABELING OF CHEMICALS. Armento, A., Kandarova, H., Klausner, M. and Hayden, P.J. MatTek Corporation, Ashland, Massachusetts, USA. Presented at 49th Annual SOT Meeting, Salt Lake City, Utah (2010).
566.	NEW!	EVALUATION OF IN VITRO MODELS FOR REACH TOXICITY TESTING: INDUCIBILITY OF XENOBIOTIC METABOLIZING ENZYME (XME) ACTIVITY IN IN VITRO HUMAN AIRWAY (EPIAIRWAY™) AND EPIDERMAL (EPIDERM™) MODELS. Bolmarcich1, J., Zhao2, G., Morgan2, L., Jackson, Jr.1, G.R., Klausner1, M., Falzareno2, T. and Hayden1, P.J. 1MatTek Corporation, Ashland, Massachusetts, USA. 2Tandem Labs, Woburn, Massachusetts, USA. Presented at 49th Annual SOT Meeting, Salt Lake City, Utah (2010).
567.	NEW!	XENOBIOTIC METABOLISM GENE EXPRESSION IN THE EPIDERM™ IN VITRO 3D HUMAN EPIDERMIS MODEL COMPARED TO HUMAN SKIN. Hu1, T., Khambatta1, Z.S., Hayden2, P.J., Bolmarcich2, J., Binder1, R.L., Robinson1, M.K., Carr1, G.J., Tiesman1, J.P., Jarrold1, B.B., Osborne1, R., Reichling1, T.D., Nemeth1, S.T., Aardema1, M.J. 1The Procter and Gamble Company, Miami Valley Innovation Center, P.O. Box 538707, Cincinnati, OH 45253, USA. 2MatTek Corporation, 200 Homer Ave., Ashland, MA 01721, USA. Toxicol. In Vitro (2010), doi:10.1016/j.tiv.2010.03.013.
568.	NEW!	EVALUATION OF PLASMACYTOID DENDRITIC CELL-BASED ASSAY TO DETERMINE CHEMICAL ALLERGENICITY Ayehunie, S., Hayden, P., Kaluzhny, Y., Child, M., Snell, M., and Klausner, M. MatTek Corporation, Ashland, MA. Presented at 49th Annual SOT Meeting, Salt Lake City, Utah (2010)
569.	NEW!	IRRITANCY AND ALLERGIC RESPONSES INDUCED BY TOPICAL APPLICATION OF ORTHO-PHTHALALDEHYDE. Anderson, S.E., Umbright, C., Sellamuthu, R., Fluharty, K., Kashon, M., Franko, J., Jackson, L.G., Johnson, V.J. and Joseph, P. Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, West Virginia 26505. Toxicological Sciences, 115(2), 435–443 (2010).
570.	NEW!	TIMECOURSE OF TH2 CYTOKINE-INDUCED GOBLET CELL HYPERPLASIA IN THE EPIAIRWAY™ IN VITRO HUMAN AIRWAY MODEL. Bolmarcich, J., Jackson, G.R. Jr., Klausner, M. and Hayden, P.J. MatTek Corporation, Ashland, MA. Presented at American Thoracic Society Meeting, New Orleans, 2010.
571.	NEW!	A NEW MODEL FOR STUDIES ON CERVICOVAGINAL INFLAMMATION AND BARRIER DISRUPTION. Blaskewicz1, C., Ayehunie2, S. and Anderson1, D. 1Boston University School of Medicine, Boston MA; 2MatTek Corp, Ashland, MA. Presented at Microbicide 2010 Conference, May 22-25, Pittsburg, PA
572.	NEW!	AN IN VITRO HUMAN AIRWAY MODEL FOR RAPID TOXICITY AND FORMULATION SCREENING OF NASAL DRUG DELIVERY SYSTEMS. Hayden, P.J., Bolmarcich, J., Jackson Jr., G.R., Cohen, H., Stolper, G., and Klausner, M. MatTek Corporation, Ashland, MA, USA. Presented at Respiratory Drug Delivery 2010, Orlando FL.
573.	NEW!	INHIBITION OF CRYSTALLIZATION IN DRUG-IN-ADHESIVE-TYPE TRANSDERMAL PATCHES. Jain, P., Banga, A.J. Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, 3001 Mercer University Drive, Mercer University, Atlanta, GA 30341-4155, United States. Inter. J. of Pharmaceutics, 394, 68–74, 2010.
574.	NEW!	EFFECTS OF GALACTOMYCES FERMENT FILTRATE ON EPIDERMAL BARRIER MARKER CASPASE-14 IN HUMAN SKIN CELLS. Hattori1, K., Date2, A., Nakajima2, A., Ishida2, K., Yan2, X., Yoshii2, T., Tamura1, H. 1Department of Hygienic Chemistry, Faculty of Pharmacy, Keio University, Tokyo, Japan. 2P&G Beauty & Grooming, Kobe, Japan. 68th Annual Meeting of Amer. Acad. of Derm., Miami, FL, March 2010. 68th Annual Meeting of Amer. Acad. of Derm., Miami, FL, March 2010.
575.	NEW!	A TIERED APPROACH TO THE USE OF ALTERNATIVES TO ANIMAL TESTING FOR THE SAFETY ASSESSMENT OF COSMETICS: GENOTOXICITY. A COLIPA ANALYSIS. Pfuhler1, S., Kirst2, A., Aardema1, M., Banduhn3, N., Goebel4, C., Araki5, D., Costabel-Farkas6, M., Dufour7, E., Fautz2, R., Harvey8, J., Hewitt9, N.J., Hibatallah10, J., Carmichael11, P., Macfarlane11, M., Reisinger3, K., Rowland12, J., Schellauf13, F., Schepky14, A., Scheel3, J. 1Procter & Gamble, Miami Valley Laboratories, 11810 East Miami River Road, Cincinnati, 45253 OH, USA. 2KPSS – Kao Professional Salon Services GmbH, Pfungstaedter Strasse 92-100, 64297 Darmstadt, Germany. 3Henkel AG & Co. KGaA, Henkelstraße 67, 40589 Düsseldorf, Germany. 4Procter & Gamble, Darmstadt Innovation Center, Berliner Allee 65, 64274 Darmstadt, Germany. 5Kanebo Cosmetics, 89/91 Rue du Faubourg St Honoré, 75008 Paris, France. 6Johnson & Johnson GmbH, Johnson&Johnson-Platz 2, D-41470 Neuss, Germany. 7L’Oreal, River Plaza 25-29, quai Aulagnier 92600 Asnières-sur-Seine, France. 8GlaxoSmithKline R&D, Ware, Hertfordshire, UK.9Scientific Writing Services, Wingertstrasse 25, 64390 Erzhausen, Germany. 10Chanel Parfums Beaute 135, Avenue Charles de Gaulle, 92525 Neuilly sur Seine, France. 11Unilever, Colworth Science Park, Sharnbrook, Bedford MK44 1LQ, UK. 12GlaxoSmithKline Consumer HealthCare R&D, Weybridge, Surrey KT13 ODE, UK. 13COLIPA, Avenue Herrmann Debroux 15A, B-1160 Auderghem, Brussels, Belgium. 14Beiersdorf AG, BF 682, Unnastrasse 48, 20245 Hamburg, Germany. Regulatory Toxicol. and Pharmacol., 57, 315-324, (2010).
576.	NEW!	COMPARATIVE STUDIES ON THE BIOTRANSFORMATION OF BENZO[A]PYRENE IN HUMAN KERATINOCYTES, IN VITRO SKIN MODELS, AND SKIN EX VIVO: METABOLITE PATTERNS AS INDICATOR FOR THE METABOLIC CAPACITY OF SKIN EQUIVALENTS Brinkmann1, J., Hutzler1, C., Trappe1, S., Stolpmann1, K., Bock2, U., Liebsch3, M., Henkler1, F., and Luch1,3, A. 1Federal Institute for Risk Assessment (BfR). Thielallee 88-92, 14195 Berlin. 2Across Barriers GmbH, Science Park 1, 66123 Saarbrucken. 3BfR-ZEBET, Center for Alternatives to Animal Testing, Diedersdorfer Weg 1, 12277 Berlin. Presented at: Skin In Vitro 2010 conference, Frankfurt, Germany, June 08 - June 09, 2010.
577.	NEW!	SAFETY TESTING OF SILICONE ELASTOMER MATRIX VAGINAL RINGS CONTAINING UC781 AND TWEEN 80 USING EPIVAGINAL(VEC-606) TISSUES. McConville1, C., Woolfson1, A.D., Elgendy2, H., Friend2, D., Malcolm1, R.K. 1School of Pharmacy, Queens University of Belfast, Belfast, UK 2CONRAD, Arlington, VA, USA. Presented at Microbicide 2010 Meeting, Pittsburgh, PA May 22-15, 2010.
578.	NEW!	PHARMACOLOGICAL PROPERTIES OF N-(3,5-DIAMINO-6-CHLOROPYRAZINE- 2-CARBONYL)-N’-4-[4-(2,3-DIHYDROXY-PROPOXY)PHENYL]BUTYL-GUANIDINE METHANE-SULFONATE (552-02), A NOVEL EPITHELIAL SODIUM CHANNEL BLOCKER WITH POTENTIAL CLINICAL EFFICACY FOR CYSTIC FIBROSIS LUNG DISEASE. Hirsh1, A.J., Zhang2, J., Zamurs1, A., Fleegle1, J., Thelin3, W.R., Caldwell3, R.A., Sabater4, J.R., Abraham4, W.M., Donowitz5, M., Cha5, B., Johnson1, K.B., St. George1, J.A., Johnson1, M.R., and Boucher3, R.C. 1Parion Sciences Inc., Durham, North Carolina; 2Albany Molecular Research Inc., Albany, New York; 3Cystic Fibrosis/Pulmonary Research and Treatment Center, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; 4Division of Pulmonary and Critical Care Medicine, University of Miami at Mount Sinai Medical Center, Miami Beach, Florida; and 5Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland. J. of Pharma. and Exper. Therapeutics, 325(1), 77-78, 2008.

(100 to 119) (120 to 139) (140 to 159) (160 to 178) (179 to 198) (199 to 218) (219 to 238) (239 to 258) (259 to 278) (279 to 298) (299 to 318) (319 to 338) (339 to 358) (359 to 378) (379 to 398) (399 to 418) (419 to 438) (439 to 458) (459 to 478) (479 to 498) (499 to 518) (519 to 538) (539 to 558) ( This Page ) (579 to 598) (599 to 611)

Skin Irritation Test Training VIDEO:

ECVAM-Validated EpiDerm SIT Protocol - Training VIDEO Now Available!

To View the VIDEO:
Click on this Link